Vanguard Fiduciary Trust
ZYME icon

Vanguard Fiduciary Trust’s Zymeworks ZYME Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09M Sell
80,120
-4,283
-5% -$109K ﹤0.01% 2644
2026
Q1 		$2.11M Buy
+84,403
New +$2M ﹤0.01% 2535

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Vanguard Fiduciary Trust's ZYME Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Zymeworks (ZYME) stake by 5.1% in Q2 2026, selling an estimated $109K and leaving 80,120 shares worth $2.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2644.

Vanguard Fiduciary Trust first reported a position in ZYME in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.11M in Q1 2026. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Vanguard Fiduciary Trust held 80,120 shares of Zymeworks worth $2.09M as of Q2 2026.
  • Vanguard Fiduciary Trust sold 4,283 Zymeworks shares in Q2 2026, an estimated $109K.
  • Zymeworks made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2644 holding.
  • Vanguard Fiduciary Trust first reported a position in Zymeworks in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Zymeworks position peaked at $2.11M in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.